CRP predicts tolerance of treatment and overall survival with weekly carboplatin-paclitaxel and concomitant irradiation for locally advanced non-small cell lung cancer

K. Webber, A. Fontela, N. Bonner, J. Bell, J. Bucci, C.R. Lewis, P.L. De Souza, P.H. Graham, M.J. Links

Research output: Contribution to journalMeeting AbstractOther

Original languageEnglish
Pages (from-to)S864-S865
Number of pages2
JournalJournal of Thoracic Oncology
Volume4
Issue number9:S1
Publication statusPublished - 2009
EventWorld Conference on Lung Cancer 2009 - San Fransciso, United States of America
Duration: 31 Jul 20094 Aug 2009
Conference number: 13th

Keywords

  • Oncology
  • Respiratory System

Cite this

Webber, K., Fontela, A., Bonner, N., Bell, J., Bucci, J., Lewis, C. R., De Souza, P. L., Graham, P. H., & Links, M. J. (2009). CRP predicts tolerance of treatment and overall survival with weekly carboplatin-paclitaxel and concomitant irradiation for locally advanced non-small cell lung cancer. Journal of Thoracic Oncology, 4(9:S1), S864-S865.